NWBO vs. AVAV
NWBO (Northwest Biotherapeutics, Inc.) and AVAV (AeroVironment, Inc.) are both stocks. NWBO operates in Biotechnology (Healthcare), while AVAV operates in Aerospace & Defense (Industrials). Over the past 10 years, NWBO returned -9.39%/yr vs 18.22%/yr for AVAV. Their 0.07 correlation means their historical movements had little consistent relationship.
Performance
NWBO vs. AVAV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NWBO achieves a -28.31% return, which is significantly higher than AVAV's -38.25% return. Over the past 10 years, NWBO has underperformed AVAV with an annualized return of -9.39%, while AVAV has yielded a comparatively higher 18.22% annualized return.
NWBO
- 1D
- -0.61%
- 1M
- -11.45%
- 6M
- -43.62%
- YTD
- -28.31%
- 1Y
- -35.62%
- 3Y*
- -32.04%
- 5Y*
- -32.84%
- 10Y*
- -9.39%
- ALL TIME*
- -30.38%
AVAV
- 1D
- 1.91%
- 1M
- -21.75%
- 6M
- -46.35%
- YTD
- -38.25%
- 1Y
- -42.57%
- 3Y*
- 15.09%
- 5Y*
- 8.12%
- 10Y*
- 18.22%
- ALL TIME*
- 9.59%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $190.78M | $258.41M | $271.62M | |
| $362.88K | $599.45K | $662.34K |
NWBO vs. AVAV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NWBO Northwest Biotherapeutics, Inc. | -28.31% | -16.74% | -60.81% | -10.64% | 12.07% | -54.10% | 626.19% | 2.19% | -14.38% | -31.05% |
AVAV AeroVironment, Inc. | -38.25% | 57.18% | 22.10% | 47.14% | 38.09% | -28.62% | 40.75% | -9.14% | 20.99% | 109.32% |
Correlation
The correlation between NWBO and AVAV is 0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.03 |
Correlation (3Y) Balances recent behavior with more history. | 0.05 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.07 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.06 |
Correlation (All Time) Calculated using the full available price history since Jan 23, 2007 | 0.07 |
Fundamentals
NWBO:
$266.22M
AVAV:
$7.56B
NWBO:
-$0.06
AVAV:
-$5.41
NWBO:
261.15
AVAV:
5.17
NWBO:
$937.00K
AVAV:
$1.42B
NWBO:
$416.00K
AVAV:
$246.70M
NWBO:
-$79.62M
AVAV:
-$6.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NWBO vs. AVAV — Risk / Return Rank
NWBO
AVAV
NWBO vs. AVAV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Northwest Biotherapeutics, Inc. (NWBO) and AeroVironment, Inc. (AVAV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NWBO | AVAV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.10 | ||
| Sortino ratioReturn per unit of downside risk | +0.15 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 0.93 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | -0.63 | -0.67 | +0.03 |
| Martin ratioReturn relative to average drawdown | -1.19 | -1.08 | -0.11 |
Loading charts...
Drawdowns
NWBO vs. AVAV - Drawdown Comparison
The maximum NWBO drawdown since its inception was -99.99%, which is greater than AVAV's maximum drawdown of -66.65%. Use the drawdown chart below to compare losses from any high point for NWBO and AVAV.
Loading charts...
Drawdown Indicators
| NWBO | AVAV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -66.65% | -33.34% |
Max Drawdown (1Y)Largest decline over 1 year | -52.03% | -66.65% | +14.62% |
Max Drawdown (3Y)Largest decline over 3 years | -85.24% | -66.65% | -18.59% |
Max Drawdown (5Y)Largest decline over 5 years | -91.96% | -66.65% | -25.31% |
Max Drawdown (10Y)Largest decline over 10 years | -93.33% | -66.65% | -26.68% |
Current DrawdownCurrent decline from peak | -99.99% | -63.55% | -36.44% |
Average DrawdownAverage peak-to-trough decline | -97.16% | -28.94% | -68.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.64% | 40.94% | -13.30% |
Volatility
NWBO vs. AVAV - Volatility Comparison
The current volatility for Northwest Biotherapeutics, Inc. (NWBO) is 17.38%, while AeroVironment, Inc. (AVAV) has a volatility of 23.79%. This indicates that NWBO experiences smaller price fluctuations and is considered to be less risky than AVAV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NWBO | AVAV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.38% | 23.79% | -6.41% |
Volatility (6M)Calculated over the trailing 6-month period | 38.84% | 59.10% | -20.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.37% | 74.38% | -8.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 82.08% | 57.67% | +24.41% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 92.64% | 52.98% | +39.66% |
Dividends
NWBO vs. AVAV - Dividend Comparison
Neither NWBO nor AVAV has paid dividends to shareholders.
Financials
NWBO vs. AVAV - Financials Comparison
This section allows you to compare key financial metrics between Northwest Biotherapeutics, Inc. and AeroVironment, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NWBO and AVAV have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVAV has higher volatility (23.79%) compared to NWBO (17.38%). In terms of maximum drawdown, NWBO dropped -99.99% vs AVAV's -66.65%.
NWBO currently has the higher Sharpe Ratio (-0.50 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NWBO and AVAV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer